Events Overview




The ACTA Statistics in Trials Interest Group (ACTA STInG) consists of a group of statisticians and clinicians with an interest in statistics who work in clinical trials across Australia and who wish to promote the practice and recognition of the importance of statistics and the profession within clinical trials. The ACTA STInG was officially launched in October 2015 at the first ACTA annual conference.

The primary aim of the group is to improve the statistical quality of investigator initiated clinical trials within Australia through enhanced collaboration among trial statisticians, and to provide a resource for contacting statisticians working in this particular research field.

The activities of the ACTA STInG are managed by an Executive Committee comprising five members of the interest group who may be contacted via the contact details below.


The specific objectives of the ACTA STInG are:

  • To improve the quality of investigator-initiated clinical trials within Australia by strengthening links among trial statisticians.
  • To develop a structured support network for trial statisticians across Australia, within which different centres provide specialist support for particular trial designs or clinical areas.
  • To work with ACTA to increase recognition and advocate within the research community (including ethics committees and with the NHMRC) for the importance of professional statistical support in the conduct of trials.
  • To promote collaborative methodological research among trial statisticians in clinical trial design and analysis.
  • To promote professional standards of statistics in trials and where possible harmonise attitudes to the practice of statistics in clinical trials settings within Australia.
  • To develop a strategy for training and mentoring future generations of trial statisticians within Australia.


Membership of the ACTA STInG is free and open to statisticians and clinicians with an interest in statistics who work in clinical trials within Australia and who support the objectives of the group. Membership may be requested here.  

As of December 2016, the ACTA STInG consists of 98 statisticians working in clinical trials across Australia, as well as clinicians with an interest in increasing the recognition and importance of statisticians working in clinical trials. Members are from a range of public and private research-focused organisations across Australia and New Zealand, including:

Australian Capital Territory

ACT Health, Canberra

Australian National University, Canberra

Datalytics Pty Ltd, Canberra

Therapeutic Goods Administration, Canberra

New South Wales

Biogen, Sydney

Cerebral Palsy Alliance, Sydney

Datapharm Australia, Sydney

Melanoma Research Institute, Wollstonecraft

NeuRA, Sydney

NHMRC Clinical Trials Unit, Sydney

Paediatric Trials Network Australia, Sydney

Pharmaxis, Sydney

The George Institute for Global Health, Sydney

The Kirby Institute, Sydney

The University of New South Wales, Sydney

The University of Sydney

The Westmead Institute for Medical Research, Sydney

University of Technology, Sydney

WriteSource Medical Pty Ltd, Sydney

Northern Territory

Menzies School of Health Research, Darwin

Royal Darwin Hospital


Australasian Kidney Trials Network, Brisbane

Griffith University, Brisbane

Integrated Health Group Pty Ltd, Brisbane

QIMR Berghofer Medical Research Institute, Brisbane

University of Queensland, Brisbane

South Australia

CPR Pharma Services, Adelaide

Flinders University, Adelaide

South Australian Health and Medical Research Institute (SAHMRI), Adelaide

The University of Adelaide


Australasian Cochrane Centre, Melbourne

Centre for Eye Research, Melbourne

Melbourne Children’s Trials Centre at the Royal Children’s Hospital

Monash University, Melbourne

Orygen, Melbourne

Peter MacCallum Cancer Centre, Melbourne

Seqirus, Melbourne

Swinburne University of Technology, Melbourne

The Alfred Hospital, Melbourne

The Florey Institute for Neuroscience and Mental Health, Melbourne

The Royal Melbourne Hospital, Melbourne

The University of Melbourne, Melbourne

Western Australia

Princess Margaret Hospital, Perth

The Telethon Institute, Perth

The University of Notre Dame, Fremantle

University of Western Australia, Perth

New Zealand

Cancer Trials New Zealand, The University of Auckland

Executive Committee

The Executive committee for the ACTA STInG consists of the following five members:

  • Katherine Lee, Melbourne Children’s Trials Centre, Royal Children’s Hospital, Melbourne
  • Laurent Billot, The George Institute for Global Health, University of Sydney, Sydney
  • Sabine Braat, The University of Melbourne, Melbourne
  • Elaine Pascoe, Australasian Kidney Trials Network, University of Queensland, Brisbane
  • Julie Marsh, Telethon Kids Institute, Perth

If you would like to contact a member of the Executive committee please use the contact details below.

Grant Advice for Trial Statisticians

One request that came up at the various meetings of the ACTA-STInG was to provide advice for applying for funding for statistical support for a trial and methodological research. In response to this request we have put together some guidance based on our experience of applying for competitive funding, which can be found at  ACTA_STInG_Grant_Advice_16Aug2017. If members have any comments on this document please let us know.

ACTA STInG Members Survey

One of the objectives of the ACTA STInG is “To develop a structured support network for trial statisticians across Australia, within which different centres provide specialist support for particular trial designs or clinical areas.” In order for us develop a better understanding of the landscape of statistical input and experience in trials across the country, we conducted a short survey of ACTA STInG members. We also asked members how ACTA STInG can be used to improve recognition of and collaboration between statisticians. This survey was completed by 68 members of the group.

See 2016 ACTA STInG Members Survey Results for more information

Useful Resources

The CONSORT (Consolidated Standards of Reporting Trials) statement – s an evidence-based, minimum set of recommendations for reporting randomized trials.

ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)

EQUATOR network (Enhancing the QUAlity and Transparency Of health Research)

Guidelines for the Content of Statistical Analysis Plans in Clincal Trials (Journal of the American Medical Association)


Explainer: how do drugs get from the point of discovery to the pharmacy shelf? (The Conversation; 11 October 2017)

Randomised control trials: what makes them the gold standard in medical research? (The Conversation; 11 October 2017)


Contact ACTA STInG

Enquiries about the ACTA Statistics in Trials Interest Group can be sent to